Frank Pallone actually said...
And the problem I have is if we grant exclusivity, we are essentially giving the pharmaceutical free rein to charge whatever it wants during that time period.
Context
Pallone expresses concern about granting exclusivity to pharmaceutical companies.
06/10/2014